Although the effects of APE1/Ref-1 on diverse transcriptional targets have been extensively examined in various types of cancers and diseases, its impact on other transcriptional targets within the context of IBD remains unexplored. The gene discussed is APEX1; the disease is inflammatory bowel disease.